A Majority of Subjects in Jaguar Health's Placebo-Controlled Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Chose to Continue on to Stage II
Synchron Appoints Andy Rasdal to Board of Directors
BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Long-Term Data Presented at ASH Support beti-cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels
Brinker International Appoints New President of Maggiano's Little Italy
Chili's Goes Back to the '90s With Boyz II Men to Create New Version of the Brand's Iconic Baby Back Ribs Jingle
Maggiano's Little Italy® Celebrates the Holidays with Festive Favorites for Thanksgiving
BRINKER INTERNATIONAL REPORTS FIRST QUARTER OF FISCAL 2024 RESULTS; AND UPDATES FISCAL 2024 GUIDANCE
 10   11   12   13   14     15    16   17   18   19   20 
 <<   <   >   >>